Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

JP Morgan Maintains Overweight on Luminar Technologies, Raises Price Target to $20

JP Morgan analyst Samik Chatterjee maintains Luminar Technologies (NASDAQ:LAZR) with a Overweight and raises the price target from $15 to $20.
byBenzinga Newsdesk
March 7, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

JP Morgan analyst Samik Chatterjee maintains Luminar Technologies (NASDAQ:LAZR) with a Overweight and raises the price target from $15 to $20.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Regeneron Announced New REGN5458 (BCMAxCD3) Phase 1 Data Show 75% Response Rate at Highest Dose Levels Studied in Patients with Heavily Pretreated Multiple Myeloma at ASH 2021

By Charles Gross
Today, 10:41 AM
egeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced new results for higher dose level cohorts of its investigational REGN5458 (BCMAxCD3) bispecific antibody, which were presented in an oral session at the 2021 American Society of Hematology (ASH) Annual Meeting in Atlanta, GA.

REGN